There are 2789 resources available
484P - CD300c blockade promotes anti-cancer immunity and synergizes with immune checkpoint inhibitor in colon cancer
Presenter: HyeRim Shin
Session: ePoster Display
485P - A phase Ib study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: The preliminary result of CEFRU study
Presenter: YONG LI
Session: ePoster Display
602P - Prevalence of castration-resistant prostate cancer (CRPC) of unknown metastatic status in the real-world setting: The AfrODiTA study
Presenter: Miguel Rodrigo-Aliaga
Session: ePoster Display
603P - Objective computerized cognitive assessment in men with metastatic castrate-resistant prostate cancer (mCRPC) randomly receiving darolutamide or enzalutamide in the ODENZA trial
Presenter: Emeline Colomba
Session: ePoster Display
604P - Predictive genomic biomarkers in non-metastatic castration resistant prostate cancer (nmCRPC) treated with androgen receptor pathway inhibitors (ARPi)
Presenter: Richard Gagnon
Session: ePoster Display
605P - Analysis of serial PET imaging and paired Tc99 scans in metastatic castration resistant prostate cancer (mCRPC) treated with enzalutamide
Presenter: Ravi Madan
Session: ePoster Display
606P - Role of serum biomarkers of bone metabolism in metastatic castration-resistance prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): PRORADIUM study final results
Presenter: Nuria Romero Laorden
Session: ePoster Display
494P - Early-onset colorectal cancer: 10-year cases documented in a comprehensive cancer centre illustrate the importance of a growing oncological problem
Presenter: Jose Carlos Ruffinelli
Session: ePoster Display
495P - Clinical characteristics, prognostic factors and survival of early-onset colorectal cancer (EOCRC) in a Spanish cohort
Presenter: Javier Soto Alsar
Session: ePoster Display